Baipsyth: China Merchants Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Beijing Baipsis Biotechnology Co., Ltd.
Bepsyth: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions in the share repurchase
Bepsyth: 301080 Bepsis Investor Relations Management Information 20240830
Bepsyth: Announcement on the plan to repurchase the company\'s shares
Bepsyth: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Bipsyth: Announcement on Accruing Asset Impairment Losses and Credit Impairment Losses for the Semi-Annual Year 2024
Bepsyth: 2024 Semi-Annual Report Summary
Bypsies: Summary table on the occupation of non-operating funds and other related capital transactions
Bepsyth: 2024 Semi-Annual Report
Bepsyth: Supervisory Board Resolution Announcement
Bepsyth: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Bepsyth: Announcement of Board Resolutions
Acrobiosystems: Company bylaws (July 2024)
Acrobiosystems: Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Acrobiosystems: Announcement of Annual Equity Distribution Implementation in 2023
Acrobiosystems: Announcement on the resignation of the company's senior management
Acrobiosystems: Notice on providing guarantees for employees' rental housing
Acrobiosystems: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Acrobiosystems: Announcement of Resolutions of the 7th Meeting of the 2nd Board of Directors
Acrobiosystems: Legal Opinion of Shanghai Tongli Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Baipsis Biotechnology Co., Ltd.
No Data